Chief Quality Officer
Gregory A. Maynard is not currently accepting new patients. For assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
UC Davis Medical Center
2315 Stockton Blvd.
Sacramento, CA 95817
Phone: 800-2-UCDAVIS (800-282-3284)
I strive to provide compassionate and professional care in the inpatient setting, along with other members of the healthcare team, partnering with the patient and their family.
Dr. Maynard's clinical interests are in quality improvement and safety of healthcare systems.
Dr. Maynard's research interests parallel his clinical and operational improvement interests; improving the quality, safety, and efficiency of patient care with research like rigor and innovative methods. He has extensive experience and publications focused on DVT prevention, inpatient glycemic control, prevention of adverse drug events, and transitions of care.
Administration
B.S., Western Illinois University, Macomb IL 1979
M.D., University of Illinois College of Medicine, Peoria IL 1983
M.S., Biostatistics and Clinical Research Design, University of Michigan, Ann Arbor MI 1993
Internal Medicine, Good Samaritan Regional Medical Center/Carl Hayden VA, Phoenix AZ 1983-1984
Internal Medicine, Good Samaritan Regional Medical Center/Carl Hayden VA, Phoenix AZ 1984-1986
Chief Resident-Internal Medicine, Good Samaritan Regional Medical Center/Carl Hayden VA, Phoenix AZ 1986-1987
Healthcare-Associated VTE Prevention Challenge Champion, CDC, 2016
Master in Hospital Medicine, Society of Hospital Medicine (SHM), 2016
2011 John M. Eisenberg Patient Safety and Quality Award for SHM, from TJC / CMS, 2012
Venous Research Award for Implementation of Best Practices, Venous Disease Coalition, 2009
National Team Improvement Award, Society of Hospital Medicine, 2008
ACP Hospitalist Top Hospitalist Award, American College of Physicians, 2008
Spyropoulos AC, Ageno W, Albers GW, Elliott CG, Halperin JL, Hiatt WR, Maynard GA, Steg PG, Weitz JI, Lu W, Spiro TE, Barnathan ES, Raskob GE. Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients. J Am Coll Cardiol. 2020 Jun 30;75(25):3140-3147. doi:10.1016/j.jacc.2020.04.071. PMID:32586587.
Spyropoulos AC, Ageno W, Albers GW, Elliott CG, Halperin JL, Hiatt WR, Maynard GA, Steg PG, Weitz JI, Suh E, Spiro TE, Barnathan ES, Raskob GE; MARINER Investigators. Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness. N Engl J Med. 2018 Sep 20;379(12):1118-1127. doi:10.1056/NEJMoa1805090. Epub 2018 Aug 26. PMID:30145946.
Jenkins IH, White RH, Amin AN, Afsarmanesh N, Auerbach AD, Khanna R, Maynard GA. Reducing the incidence of hospital-associated venous thromboembolism within a network of academic hospitals: Findings from five University of California medical centers. J Hosp Med. 2016 Dec;11 Suppl 2:S22-S28. doi:10.1002/jhm.2658. PMID:27925421.
Maynard G. Preventing hospital-associated venous thromboembolism: a guide for effective quality improvement, 2nd ed., Agency for Healthcare Research and Quality, Rockville, MD. 2015 Oct. AHRQ Publication No. 16-001-EF.
Maynard G, Kulasa K, Ramos P, Childers D, Clay B, Sebasky M, Fink E, Field A, Renvall M, Juang PS, Choe C, Pearson D, Serences B, Lohnes S. Impact of a hypoglycemia reduction bundle and a systems approach to inpatient glycemic management. Endocr Pract. 2015 Apr;21(4):355-67. doi:10.4158/EP14367.OR. Epub 2014 Dec 22. PMID:25536971.
Li J, Hinami K, Hansen LO, Maynard G, Budnitz T, Williams MV. The physician mentored implementation model: a promising quality improvement framework for health care change. Acad Med. 2015 Mar;90(3):303-10. doi:10.1097/ACM.0000000000000547. PMID:25354069.
Maynard G, Schnipper JL, Messler J, Ramos P, Kulasa K, Nolan A, Rogers K. Design and implementation of a web-based reporting and benchmarking center for inpatient glucometrics. J Diabetes Sci Technol. 2014 Jul;8(4):630-40. doi:10.1177/1932296814532237. Epub 2014 May 12. PMID:24876426.
Hofflich HL, Oh DK, Choe CH, Clay B, Tibble C, Kulasa KM, Shah PK, Fink E, Girard PJ, Schwartz AK, Maynard GA. Using a triggered endocrinology service consultation to improve the evaluation, management, and follow-up of osteoporosis in hip-fracture patients. Jt Comm J Qual Patient Saf. 2014 May;40(5):228-34. doi:10.1016/s1553-7250(14)40030-8. PMID:24919254.
Khanna R, Maynard G, Sadeghi B, Hensley L, Medvedev S, Danielsen B, White RH. Incidence of hospital-acquired venous thromboembolic codes in medical patients hospitalized in academic medical centers. J Hosp Med. 2014 Apr;9(4):221-5. doi:10.1002/jhm.2159. Epub 2014 Feb 5. PMID:24497463.
Maynard G, Humber D, Jenkins I. Multidisciplinary initiative to improve inpatient anticoagulation and management of venous thromboembolism. Am J Health Syst Pharm. 2014 Feb 15;71(4):305-10. doi:10.2146/ajhp130108. PMID:24481155.